Author: pharmacybiz

The General Pharmaceutical Council (GPhC) has unveiled its Carbon Net Zero Action Plan for sustainable pharmacy regulation, aiming to achieve carbon net zero by 2040. The action plan focuses on three... Read More

Diabetes is recognised as a major cause of blindness, kidney failure, heart attacks, stroke and lower limb amputation. According to World Health Oragnization (WHO), more than 95 per cent of people... Read More

A new report from Community Pharmacy England (CPE) has raised alarms about the severe financial challenges plaguing pharmacies across the sector, threatening their ability to provide even the core services... Read More

A new report published by the NHS Business Services Authority (NHSBSA) reveals that 24,300 dentists performed NHS dental activity in England in 2023/24, marking a 0.4 per cent rise from... Read More

The Royal Pharmaceutical Society (RPS) has taken a neutral stance on the Assisted Dying for Terminally Ill Adults (Scotland) Bill but underscores that pharmacists should have the right to refuse... Read More

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved lecanemab (Leqembi) for use in the early stages of Alzheimer’s disease, following a thorough review of the drug’s benefits and... Read More

“We’re thrilled that MedicinesComplete will now be available to all clinicians in Wales through the NHS Wales e-Library,” said Karen Baxter, Managing Director of Pharmaceutical Press, announcing a contract with... Read More

The UK’s performance in hospital-based care is falling behind other high-income countries, according to a new report published by the Health Foundation. For hospital care waiting times, the UK ranked among... Read More

NHS England has announced the expansion of Electronic Prescription Service (EPS) to Detained Estate health services in England, starting next month. This means prescribers working in prisons would be able to... Read More

The National Institute for Health and Care Excellence (NICE) has made a new recommendation in its final guidance this week that could benefit almost 30,000 adults suffering from moderate to... Read More